SNCA

Q: What is the price of Seneca Biopharma (SNCA) today?

The current price of Seneca Biopharma (SNCA) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Seneca Biopharma (SNCA) pay dividends?

Seneca Biopharma (SNCA) did not pay dividends over the past year.

Seneca Biopharma Inc.

Price

$ -

return (12m)

0.00%

p/e

-10.59

p/bv

17.64

DIVIDEND YIELD

0.00%

SNCA price

SNCA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment SNCA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals SNCA

review the fundamentals of Seneca Biopharma shares

P/E

-10.59

Sector: -3.96 Industry: -3.96

P/S (PSR)

12,741.53

Sector: -3.88 Industry: -3.88

P/BV

17.64

Sector: 1.87 Industry: 1.87

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-124.66%

Sector: -61.39% Industry: -61.39%

ROE

-166.53%

Sector: -60.71% Industry: -60.71%

ROIC

Sector: -1,194.93% Industry: -1,194.93%

NET MARGIN

-100.00%

Sector: -39.39% Industry: -39.39%

GROSS MARGIN

18.59%

Sector: 38.09% Industry: 38.09%

OPERATING MARGIN

-100.00%

Sector: -39.58% Industry: -39.58%

EV/EBITDA

-14.53

Sector: -3.80 Industry: -3.80

EV/EBIT

-14.42

Sector: -4.02 Industry: -4.02

PRICE-TO-ASSETS

13.20

Sector: 1.38 Industry: 1.38

BVPS

3.39

Sector: 1.89 Industry: 1.89

EPS

-5.64

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.75

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.75

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals SNCA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.88	7.40	33.81%	2.14%	$ 586.59 B	28.46%
PFE	20.06	1.67	8.35%	6.28%	$ 155.85 B	12.42%
ABBV	89.02	0.00	0.00%	3.12%	$ 376.19 B	6.91%
NVO	10.61	5.46	51.50%	4.98%	$ 166.18 B	33.05%
MRK	16.72	0.00	0.00%	2.70%	$ 305.21 B	28.08%
AZN	31.27	6.56	20.99%	1.55%	$ 319.77 B	17.41%
GILD	20.77	7.81	37.62%	2.24%	$ 176.72 B	28.90%
BMY	16.98	-3.52	-20.72%	4.23%	$ 119.74 B	14.64%
ZTS	19.59	15.72	80.25%	1.70%	$ 52.37 B	28.23%
REGN	17.51	2.52	14.41%	0.47%	$ 78.86 B	31.41%
HALO	24.94	161.91	649.21%	0.00%	$ 7.90 B	22.69%
AMGN	24.97	22.24	89.06%	2.70%	$ 192.51 B	20.98%
MCK	24.84	-1,089.08	-4,383.84%	0.36%	$ 107.82 B	1.09%
VRTX	28.42	6.02	21.18%	0.00%	$ 112.36 B	32.94%
CAH	30.78	-18.95	-61.56%	0.94%	$ 51.16 B	0.68%
HRMY	10.31	1.88	18.24%	0.00%	$ 1.64 B	18.27%
ADMA	16.29	5.01	30.78%	0.00%	$ 2.39 B	28.80%
BIIB	20.21	1.43	7.08%	0.00%	$ 26.12 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

SNCA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Seneca Biopharma

Seneca Biopharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

25 years

Founded: 2001

1973

Time since IPO - 53 years

7

Employees

Seneca Biopharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $172.27 Millions, with shareholders equity totaling $9.77 Millions.

The company employs approximately 7 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Seneca Biopharma Inc. reported $13.52 Thousand in revenue, generating net income of $-16.27 Millions.

Key financial metrics include a P/E ratio of -10.59, a price-to-book (P/B) ratio of 17.64, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SNCA.

Market cap

$ 172.27 Millions

Net worth

$ 9.77 Millions

$ 9,767,916.00

Assets

$ 13.05 Millions

$ 13,049,144.00

Total Shares Outstanding

2.88 Millions

2,882,000

Average Daily Trading Volume

$ 372.84 Thousand

$ 372,839.00

Sector

Health Care

Industry

Biotechnology

SNCA

SNCA revenue and profits

Financial Results SNCA

DRAG THE FRAME TO SEE MORE DATA

SNCA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 865.60 26,06% (12M)

P/E

24.84

0.36%

ROE

-4,383.84%

P/BV

-1,089.08

CAH - Cardinal Health

$ 215.52 66,01% (12M)

P/E

30.78

0.94%

ROE

-61.56%

P/BV

-18.95

JNJ - Johnson & Johnson

$ 238.46 61,54% (12M)

P/E

21.88

2.14%

ROE

33.81%

P/BV

7.40

PFE - Pfizer

$ 26.92 31,78% (12M)

P/E

20.06

6.28%

ROE

8.35%

P/BV

1.67

ABBV - AbbVie

$ 207.94 23,70% (12M)

P/E

89.02

3.12%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 121.42 58,92% (12M)

P/E

16.72

2.70%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 204.03 52,68% (12M)

P/E

31.27

1.55%

ROE

20.99%

P/BV

6.56

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 865.60 26,06% (12 M)

P/L

24.84

0.36%

ROE

-4,383.84%

P/VP

-1,089.08

CAH - Cardinal Health

$ 215.52 66,01% (12 M)

P/L

30.78

0.94%

ROE

-61.56%

P/VP

-18.95

JNJ - Johnson & Johnson

$ 238.46 61,54% (12 M)

P/L

21.88

2.14%

ROE

33.81%

P/VP

7.40

PFE - Pfizer

$ 26.92 31,78% (12 M)

P/L

20.06

6.28%

ROE

8.35%

P/VP

1.67

ABBV - AbbVie

$ 207.94 23,70% (12 M)

P/L

89.02

3.12%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 121.42 58,92% (12 M)

P/L

16.72

2.70%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 204.03 52,68% (12 M)

P/L

31.27

1.55%

ROE

20.99%

P/VP

6.56

Frequently Asked Questions

What is the price of Seneca Biopharma (SNCA) today?

The current price of Seneca Biopharma (SNCA) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Seneca Biopharma (SNCA) pay dividends?

Seneca Biopharma (SNCA) did not pay dividends over the past year.

Is Seneca Biopharma (SNCA) a good investment?

Seneca Biopharma (SNCA) is currently trading at $ 0.00 with a P/E ratio of -10.59%. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Seneca Biopharma (SNCA) stock?

You can buy Seneca Biopharma (SNCA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol SNCA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Seneca Biopharma (SNCA) yield today?

Over the past month, Seneca Biopharma (SNCA) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Seneca Biopharma (SNCA) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SNCA

Seneca Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SNCA

review the fundamentals of Seneca Biopharma shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Seneca Biopharma

Seneca Biopharma Inc.

United States

25 years

1973

7

PROFIT X PRICE SNCA

Financial Results SNCA

SNCA cash flow

Asset, Revenue and Profit Growth - SNCA

SNCA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions